| SASDDJ2 |
Calcium-bound polcalcin Phl p 7 |
O82040 | Single concentration |
1 | 1 | Published |
| SASDDJ3 |
Candida antarctica lipase B - with guanidine-HCl unfolding series |
P41365 | Single concentration |
1 | 0 | Published |
| SASDDJ4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 2 mg/ml of Y207A C1 in the absence of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDJ5 |
Mammalian prion protein mRNA (PrP mRNA wild type) with LiCl |
— | Merged |
1 | 1 | Published |
| SASDDJ6 |
SAM-dependent O-Methyltransferase from Mycobacterium hassiacum |
K5B7F3 | Extrapolated to infinite dilution |
1 | 2 | Published |
| SASDDJ7 |
Citrate-binding PAS domain from the sensor histidine kinase, CitA, fused to lipase EstA |
— | Single concentration |
1 | 1 | Published |
| SASDDJ8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant A1468D |
P16144 | Merged |
1 | 1 | Published |
| SASDDJ9 |
Conformation of the R1-3 human dystrophin fragment (SANS) |
P11532 | Single concentration |
1 | 1 | Published |
| SASDDK2 |
Aspergillus fumigatus UDP galactopyranose mutase |
— | Single concentration |
1 | 1 | Published |
| SASDDK3 |
Candida antarctica lipase B - with guanidine-HCl unfolding series, in the presence of dithiothreitol |
P41365 | Single concentration |
1 | 0 | Published |
| SASDDK4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 4 mg/ml of Y207A C1 in the absence of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDK5 |
Mammalian prion protein mRNA (PrP mRNA wild type) with KCl and pyridostatin (PDS) |
— | Merged |
1 | 1 | Published |
| SASDDK7 |
Disrupted-in-Schizophrenia 1 protein (DISC1 12d2) |
Q9NRI5 | Single concentration |
1 | 2 | Published |
| SASDDK8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant R1475E |
P16144 | Merged |
1 | 2 | Published |
| SASDDK9 |
Conformation of R1-3 human dystrophin fragment in interaction with zwitterionic phospholipid bicelles (SANS) |
P11532 | Single concentration |
1 | 1 | Published |
| SASDDL2 |
Sinorhizobium meliloti Proline Utilization A (PutA) lowest concentration, 1.00 mg/ml |
F7X6I3 | Single concentration |
1 | 1 | Published |
| SASDDL3 |
Folded ribonuclease A (RNAse) |
P61823 | Single concentration |
1 | 1 | Published |
| SASDDL4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 8 mg/ml of Y207A C1 in the absence of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDL5 |
Mutant mammalian prion protein mRNA (octo-repeat PrP mRNA) |
— | Merged |
1 | 1 | Published |
| SASDDL6 |
Calcium Loaded Calbindin-D28K |
P05937 | SEC-SAS |
1 | 2 | Published |
| SASDDL7 |
anti-DISC1 single-domain camelid antibody VHH B5 |
— | Merged |
1 | 2 | Published |
| SASDDL8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant R1475A |
P16144 | Merged |
1 | 2 | Published |
| SASDDL9 |
Conformation of R1-3 human dystrophin fragment in interaction with anionic phospholipid bicelles (SANS) |
P11532 | Single concentration |
1 | 1 | Published |
| SASDDM2 |
Sinorhizobium meliloti Proline Utilization A (PutA) at 2.00 mg/ml |
F7X6I3 | Single concentration |
1 | 1 | Published |
| SASDDM3 |
Carboyxamidomethylated ribonuclease A (unfolded RNAse) - with and without urea |
P61823 | Single concentration |
1 | 0 | Published |
| SASDDM4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 2 mg/ml of Y207A C1 in 1 mM of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDM5 |
Mutant mammalian prion protein mRNA (octo-repeat PrP mRNA) with KCl |
— | Merged |
1 | 1 | Published |
| SASDDM6 |
Calbindin-D28K |
P05937 | SEC-SAS |
1 | 1 | Published |
| SASDDM7 |
Complex of disrupted-in-Schizophrenia 1 protein (DISC1 12D2) and anti-DISC1 single-domain camelid antibody VHH B5 |
Q9NRI5 | Single concentration |
1 | 1 | Published |
| SASDDM8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant R1542E |
P16144 | Merged |
1 | 2 | Published |
| SASDDM9 |
lipoprotein lipase–GPIHBP1 complex |
P06858 | Single concentration |
1 | 1 | Published |
| SASDDN2 |
Sinorhizobium meliloti Proline Utilization A (PutA) at 3.00 mg/ml |
F7X6I3 | Single concentration |
1 | 1 | Published |
| SASDDN3 |
Bovine serum albumin mixture: averaged and individual data frames (subtracted and unsubtracted test sets) |
P02769 | Single concentration |
1 | 0 | Published |
| SASDDN4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 4 mg/ml of Y207A C1 in 1 mM of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDN5 |
Mutant mammalian prion protein mRNA (octo-repear PrP mRNA) with LiCl |
— | Merged |
1 | 1 | Published |
| SASDDN6 |
Human stress-inducible heat shock 70 kDa protein 1, Hsp70 (Hspa1a) T204A mutant dimer, in the presence of ATP |
P0DMV8 | Single concentration |
1 | 1 | Published |
| SASDDN7 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 2 mg/ml of E248A/E251A C1 in the absence of p-hydroxyphenylacetic acid (HPA) |
Q6Q271 | Single concentration |
1 | 0 | Published |
| SASDDN8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant R1542A |
P16144 | Merged |
1 | 2 | Published |
| SASDDN9 |
Mycobacterium tuberculosis DNA Ligase A |
P9WNV1 | Single concentration |
1 | 1 | Published |
| SASDDP2 |
Sinorhizobium meliloti Proline Utilization A (PutA) at high concentration, 4.00 mg/ml |
F7X6I3 | Single concentration |
1 | 1 | Published |
| SASDDP3 |
N-propargyl glycine-Inactivated Proline utilization A from Bradyrhizobium diazoefficiens (formerly Bradyrhizobium japonicum) collected by SEC-SAXS |
Q89E26 | SEC-SAS |
1 | 2 | Published |
| SASDDP4 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 8 mg/ml of Y207A C1 in 1 mM of p-hydroxyphenylacetic acid (HPA) |
— | Single concentration |
1 | 0 | Published |
| SASDDP5 |
Mutant mammalian prion protein mRNA (octo-repear PrP mRNA) with KCl and pyridostatin (PDS) |
— | Merged |
1 | 1 | Published |
| SASDDP6 |
Anti-CD32b Antibody Clone 6G08 Antibody Binding Fragment (6G08 F(ab)) |
— | Merged |
1 | 0 | Published |
| SASDDP7 |
p-hydroxyphenylacetate 3-hydroxylase, reductase component (mutant): 4 mg/ml of E248A/E251A C1 in the absence of p-hydroxyphenylacetic acid (HPA) |
Q6Q271 | Single concentration |
1 | 0 | Published |
| SASDDP8 |
Integrin beta4, fragment of the cytoplasmic region that includes the final part of the connecting segment and the third and fourth FnIII domains (FnIII-3,4). Point mutant T1663R |
P16144 | Merged |
1 | 2 | Published |
| SASDDP9 |
C-terminal half of pseudorabies virus tegument protein UL37 |
Q911W0 | SEC-SAS |
1 | 1 | Published |
| SASDDQ2 |
EspG3 chaperone from Mycobacterium marinum |
B2HNX0 | Single concentration |
1 | 0 | Published |
| SASDDQ3 |
Proline utilization A from Bradyrhizobium diazoefficiens (formerly Bradyrhizobium japonicum) collected by SEC-SAXS |
Q89E26 | SEC-SAS |
1 | 1 | Published |
| SASDDQ4 |
LIM/homeobox protein Lhx4 LIM domains fused to the LIM interaction domain (LID) of Insulin gene enhancer protein ISL-2 |
P53776,Q9CXV0 | Extrapolated to infinite dilution |
1 | 1 | Published |